Demant Sells Hearing Implant Subsidiary Oticon for $120M

Oticon Medical is being sold off by Copenhagen-based healthtech parent company Demant to another hearing implant developer. Cochlear, an Australian company, is set to pay 850 million Danish kroner (roughly $120 million) to acquire Oticon...